GlassScriptPhysician profile
Sara Beth Dawson
NPI 1245585272
$1,117.25
in general payments reported to CMS, 2019-2025
8 companies · $11.48 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $554 · 2020: $34.45 · 2021: $181 · 2022: $337 · 2025: $11.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $296.13 | 2019 | |
| Alcon Vision LLC | $238.54 | 2019-2021 | |
| Visioneering Technologies, INC. | $200.00 | 2019 | |
| Allergan, INC. | $125.00 | 2022 | |
| Glaukos Corporation | $115.58 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $96.07 | 2022 | |
| Sun Pharmaceutical Industries INC. | $34.45 | 2020 | |
| Lkc Technologies, INC. | $11.48 | 2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Dawson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.